Analysis

How Pfizer Profited From the Pandemic

July 18, 2022 0

Story at-a-glance The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something […]

Analysis

Media Hypes Moderna’s COVID Vaccine, But Downplays Risks

November 18, 2020 0

Media Hypes Moderna’s COVID Vaccine, Downplays Risks Media mostly silent on safety concerns and lack of transparency surrounding Moderna’s experimental COVID vaccine, while stakeholders get richer. By: Children’s Health Defense Team For the second time […]